1973 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Article
2018

Trabectedin and olaparib in patients with advanced and non-resectable bone and soft-tissue sarcomas (TOMAS): an open-label, phase 1b study from the Italian Sarcoma Group

Grignani, G., D'Ambrosio, L., Pignochino, Y., Palmerini, E., Zucchetti, M., Boccone, P., Aliberti, S., Stacchiotti, S., Bertulli, R., Piana, R., Miano, S., Tolomeo, F., Chiabotto, G., Sangiolo, D., Pisacane, A., Dei Tos, A. P., Novara, L., Bartolini, A., Marchesi, E., D'Incalci, M. & 4 others, Bardelli, A., Picci, P., Ferrari, S. & Aglietta, M., Oct 2018, In : The Lancet Oncology. 19, 10, p. 1360-1371 12 p.

Research output: Contribution to journalArticle

Trabectedin and olaparib in patients with advanced and non-resectable bone and soft-tissue sarcomas (TOMAS): an open-label, phase 1b study from the Italian Sarcoma Group

Grignani, G., D'Ambrosio, L., Pignochino, Y., Palmerini, E., Zucchetti, M., Boccone, P., Aliberti, S., Stacchiotti, S., Bertulli, R., Piana, R., Miano, S., Tolomeo, F., Chiabotto, G., Sangiolo, D., Pisacane, A., Dei Tos, A. P., Novara, L., Bartolini, A., Marchesi, E., D'Incalci, M. & 4 others, Bardelli, A., Picci, P., Ferrari, S. & Aglietta, M., 2018, In : The Lancet Oncology. 19, 10, p. 1360-1371 12 p.

Research output: Contribution to journalArticle

Trabectedin and olaparib in patients with advanced and non-resectable bone and soft-tissue sarcomas (TOMAS): an open-label, phase 1b study from the Italian Sarcoma Group.

Grignani, G., D'Ambrosio, L., Pignochino, Y., Palmerini, E., Zucchetti, M., Boccone, P., Aliberti, S., Stacchiotti, S., Bertulli, R., Piana, R., Miano, S., Tolomeo, F., Chiabotto, G., Sangiolo, D., Pisacane, A., Dei Tos, A. P., Novara, L., Bartolini, A., Marchesi, E., D'Incalci, M. & 4 others, Bardelli, A., Picci, P., Ferrari, S. & Aglietta, M., Oct 1 2018, In : The Lancet. Oncology. 19, p. 1360-1371 12 p.

Research output: Contribution to journalArticle

Transcriptomic analysis and mutational status of IDH1 in paired primary-recurrent intrahepatic cholangiocarcinoma

Peraldo-Neia, C., Ostano, P., Cavalloni, G., Pignochino, Y., Sangiolo, D., De Cecco, L., Marchesi, E., Ribero, D., Scarpa, A., De Rose, A. M., Giuliani, A., Calise, F., Raggi, C., Invernizzi, P., Aglietta, M., Chiorino, G. & Leone, F., Jun 5 2018, In : BMC Genomics. 19, 1, 440.

Research output: Contribution to journalArticle

Transcriptomic analysis and mutational status of IDH1 in paired primary-recurrent intrahepatic cholangiocarcinoma

Peraldo-Neia, C., Ostano, P., Cavalloni, G., Pignochino, Y., Sangiolo, D., De Cecco, L., Marchesi, E., Ribero, D., Scarpa, A., De Rose, A. M., Giuliani, A., Calise, F., Raggi, C., Invernizzi, P., Aglietta, M., Chiorino, G. & Leone, F., 2018, In : BMC Genomics. 19, 1

Research output: Contribution to journalArticle

Transcriptomic analysis and mutational status of IDH1 in paired primary-recurrent intrahepatic cholangiocarcinoma

Peraldo-Neia, C., Ostano, P., Cavalloni, G., Pignochino, Y., Sangiolo, D., De Cecco, L., Marchesi, E., Ribero, D., Scarpa, A., De Rose, A. M., Giuliani, A., Calise, F., Raggi, C., Invernizzi, P., Aglietta, M., Chiorino, G. & Leone, F., Jun 5 2018, In : BMC Genomics. 19, 1

Research output: Contribution to journalArticle

2017

Aandrogen receptor status predicts development of brain metastases in ovarian cancers

Mittica, G., Senetta, R., Scotto, G., Aglietta, M., Maggiorotto, F., Ghisoni, E., Genta, S., Boldorini, R., Manini, C., Morra, I., Buosi, R., Sapino, A., Cassoni, P. & Valabrega, G., Jan 1 2017, In : Oncotarget. 8, 25, p. 41143-41153 11 p.

Research output: Contribution to journalArticle

Alpha-fetoprotein elevation in NUT midline carcinoma: A case report

D'Ambrosio, L., Palesandro, E., Moretti, M., Pelosi, G., Fabbri, A., Carnevale Schianca, F., Aglietta, M. & Grignani, G., Apr 13 2017, In : BMC Cancer. 17, 1, 266.

Research output: Contribution to journalArticle

Alpha-fetoprotein elevation in NUT midline carcinoma: a case report

D'Ambrosio, L., Palesandro, E., Moretti, M., Pelosi, G., Fabbri, A., Carnevale Schianca, F., Aglietta, M. & Grignani, G., Apr 13 2017, In : BMC Cancer. 17, 1, p. 266

Research output: Contribution to journalArticle

Analytic and dynamic secretory profile of patient-derived cytokine-induced killer cells

Mesiano, G., Zini, R., Montagner, G., Bianchi, N., Manfredini, R., Chillemi, A., Aglietta, M., Grignani, G., Lampronti, I., Fiorino, E., Malavasi, F., Sangiolo, D., Gambari, R. & Ferrari, D., Jan 1 2017, In : Molecular Medicine. 23, p. 235-246 12 p.

Research output: Contribution to journalArticle

Cytokine-induced killer cells kill chemo-surviving melanoma cancer stem cells

Gammaitoni, L., Giraudo, L., MacAgno, M., Leuci, V., Mesiano, G., Rotolo, R., Sassi, F., Sanlorenzo, M., Zaccagna, A., Pisacane, A., Senetta, R., Cangemi, M., Cattaneo, G., Martin, V., Coha, V., Gallo, S., Pignochino, Y., Sapino, A., Grignani, G., Carnevale-Schianca, F. & 2 others, Aglietta, M. & Sangiolo, D., May 1 2017, In : Clinical Cancer Research. 23, 9, p. 2277-2288 12 p.

Research output: Contribution to journalArticle

Effect of Contract Research Organization Bureaucracy in Clinical Trial Management: A Model From Lung Cancer

Gobbini, E., Pilotto, S., Pasello, G., Polo, V., Di Maio, M., Arizio, F., Galetta, D., Petrillo, P., Chiari, R., Matocci, R., Di Costanzo, A., Di Stefano, T. S., Aglietta, M., Cagnazzo, C., Sperduti, I., Bria, E. & Novello, S., 2017, In : Clinical Lung Cancer.

Research output: Contribution to journalArticle

Front-line window therapy with cisplatin in patients with primary disseminated Ewing sarcoma: A study by the Associazione Italiana di Ematologia ed Oncologia Pediatrica and Italian Sarcoma Group.

Luksch, R., Grignani, G., D'Angelo, P., Prete, A., Puma, N., Podda, M., Casanova, M., Ferrari, A., Morosi, C., Fagioli, F., Aglietta, M., Ferrari, S., Picci, P. & Massimino, M., Jun 14 2017, In : Pediatric Blood and Cancer. 64, 12, p. 1-4 4 p.

Research output: Contribution to journalArticle

Impact of a risk-based follow-up in patients affected by gastrointestinal stromal tumour

D'Ambrosio, L., Palesandro, E., Boccone, P., Tolomeo, F., Miano, S., Galizia, D., Manca, A., Chiara, G., Bertotto, I., Russo, F., Campanella, D., Venesio, T., Sangiolo, D., Pignochino, Y., Siatis, D., De Simone, M., Ferrero, A., Pisacane, A., Dei Tos, A. P., Aliberti, S. & 2 others, Aglietta, M. & Grignani, G., Jun 1 2017, In : European Journal of Cancer. 78, p. 122-132 11 p.

Research output: Contribution to journalArticle

PARP1 expression drives the synergistic antitumor activity of trabectedin and PARP1 inhibitors in sarcoma preclinical models

Pignochino, Y., Capozzi, F., D'Ambrosio, L., Dell'Aglio, C., Basiricò, M., Canta, M., Lorenzato, A., Vignolo Lutati, F., Aliberti, S., Palesandro, E., Boccone, P., Galizia, D., Miano, S., Chiabotto, G., Napione, L., Gammaitoni, L., Sangiolo, D., Benassi, M. S., Pasini, B., Chiorino, G. & 2 others, Aglietta, M. & Grignani, G., Apr 28 2017, In : Molecular Cancer. 16, 1, 86.

Research output: Contribution to journalArticle

PARP1 expression drives the synergistic antitumor activity of trabectedin and PARP1 inhibitors in sarcoma preclinical models.

Pignochino, Y., Capozzi, F., D'Ambrosio, L., Dell'Aglio, C., Basiricò, M., Canta, M., Lorenzato, A., Vignolo-Lutati, F., Aliberti, S., Palesandro, E., Boccone, P., Galizia, D., Miano, S., Chiabotto, G., Napione, L., Gammaitoni, L., Sangiolo, D., Benassi, M. S., Pasini, B., Chiorino, G. & 2 others, Aglietta, M. & Grignani, G., Apr 28 2017, In : Molecular Cancer. 16, 1, p. 1-15 15 p.

Research output: Contribution to journalArticle

Personalization of regorafenib treatment in metastatic gastrointestinal stromal tumours in real-life clinical practice

Nannini, M., Nigro, M. C., Vincenzi, B., Fumagalli, E., Grignani, G., D’Ambrosio, L., Badalamenti, G., Incorvaia, L., Bracci, R., Gasperoni, S., Saponara, M., Gatto, L., Indio, V., Astolfi, A., Di Scioscio, V., Casali, P. G., Tonini, G., Aglietta, M., Russo, A., Biasco, G. & 1 others, Pantaleo, M. A., Dec 1 2017, In : Therapeutic Advances in Medical Oncology. 9, 12, p. 731-739 9 p.

Research output: Contribution to journalArticle

Prospective validation of a lymphocyte infiltration prognostic test in stage III colon cancer patients treated with adjuvant FOLFOX

Emile, J. F., Julié, C., Le Malicot, K., Lepage, C., Tabernero, J., Mini, E., Folprecht, G., Van Laethem, J. L., Dimet, S., Boulagnon-Rombi, C., Allard, M. A., Penault-Llorca, F., Bennouna, J., Laurent-Puig, P., Taieb, J., Thaler, J., Greil, R., Gaenzer, J., Eisterer, W., Tschmelitsch, J. & 320 others, Keil, F., Samonigg, H., Zabernigg, A., Schmid, F. X., Steger, G., Steinacher, R., Andel, J., Jagdt, B., Lang, A., Fridrik, M., Függer, R., Hofbauer, F., Woell, E., Geissler, D., Lenauer, A., Prager, M., D'Haens, G., Demolin, G., Kerger, J., Deboever, G., Ghillebert, G., Polus, M., Van Cutsem, E., Kalantari, H. R., Delaunoit, T., Goeminne, J. C., Peeters, M., Vergauwe, P., Houbiers, G., Humblet, Y., Janssens, J., Schrijvers, D., Vanderstraeten, E., Van Laethem, J. L., Vermorken, J., Van Daele, D., Ferrante, M., Forget, F., Hendlisz, A., Yilmaz, M., Nielsen, S. E., Vestermark, L., Larsen, J., Zawadi, M. A., Bouche, O., Mineur, L., Bennouna-Louridi, J., Dourthe, L. M., Ychou, M., Boucher, E., Taieb, J., Pezet, D., Desseigne, F., Ducreux, M., Texereau, P., Miglianico, L., Rougier, P., Fratte, S., Levache, C. B., Merrouche, Y., Ellis, S., Locher, C., Ramee, J. F., Garnier, C., Viret, F., Chauffert, B., Cojean-Zelek, I., Michel, P., Lecaille, C., Borel, J. C., Seitz, J. F., Smith, D., Lombard-Bohas, C., Andre, T., Gornet, J. M., Fein, F., Coulon-Sfairi, M. A., Kaminsky, M. C., Lagasse, J. P., Luet, D., Etienne, P. L., Gasmi, M., Vanoli, A., Nguyen, S., Aparicio, T., Perrier, H., Stremsdoerfer, N., Laplaige, P., Arsene, D., Auby, D., Bedenne, L., Coriat, R., Denis, B., Geoffroy, P., Piot, G., Becouarn, Y., Bordes, G., Deplanque, G., Dupuis, O., Fruge, F., Guimbaud, R., Lecomte, T., Lledo, G., Sobhani, I., Asnacios, A., Azzedine, A., Desauw, C., Galais, M. P., Gargot, D., Lam, Y. H., Abakar-Mahamat, A., Berdah, J. F., Catteau, S., Clavero-Fabri, M. C., Codoul, J. F., Legoux, J. L., Goldfain, D., Guichard, P., Verge, D. P., Provencal, J., Vedrenne, B., Brezault-Bonnet, C., Cleau, D., Desir, J. P., Fallik, D., Garcia, B., Gaspard, M. H., Genet, D., Hartwig, J., Krummel, Y., Budnik, T. M., Palascak-Juif, V., Randrianarivelo, H., Rinaldi, Y., Aleba, A., Darut-Jouve, A., de Gramont, A., Hamon, H., Wendehenne, F., Matzdorff, A., Stahl, M. K., Schepp, W., Burk, M., Mueller, L., Folprecht, G., Geissler, M., Mantovani-Loeffler, L., Hoehler, T., Asperger, W., Kroening, H., von Weikersthal, L. F., Fuxius, S., Groschek, M., Meiler, J., Trarbach, T., Rauh, J., Ziegenhagen, N., Kretzschmar, A., Graeven, U., Nusch, A., von Wichert, G., Hofheinz, R. D., Kleber, G., Schmidt, K. H., Vehling-Kaiser, U., Baum, C., Schuette, J., Haag, G. M., Holtkamp, W., Potenberg, J., Reiber, T., Schliesser, G., Schmoll, H-J., Schneider-Kappus, W., Abenhardt, W., Denzlinger, C., Henning, J., Marxsen, B., Derigs, H. G., Lambertz, H., Becker-Boost, I., Caca, K., Constantin, C., Decker, T., Eschenburg, H., Gabius, S., Hebart, H., Hoffmeister, A., Horst, H. A., Kremers, S., Leithaeuser, M., Mueller, S., Wagner, S., Daum, S., Schlegel, F., Stauch, M., Heinemann, V., Maiello, E., Latini, L., Zaniboni, A., Amadori, D., Aprile, G., Barni, S., Mattioli, R., Martoni, A., Passalacqua, R., Nicolini, M., Pasquini, E., Rabbi, C., Aitini, E., Ravaioli A., A., Barone, C., Biasco, G., Tamberi, S., Gambi, A., Verusio, C., Marzola, M., Lelli, G., Boni, C., Cascinu, S., Bidoli, P., Vaghi, M., Cruciani, G., Costanzo, F., Sobrero, A., Mini, E., Petrioli, R., Aglietta, M., Alabiso, O., Capuzzo, F., Falcone, A., Corsi, D. C., Labianca, R., Salvagni, S., Chiara, S., Ciuffreda, L., Ferraù, F., Giuliani, F., Lonardi, S., Gebbia, N., Mantovani, G., Sanches, E., Mellidez, J. C., Santos, P. G., Freire, J., Sarmento, C., Costa, J. L., Pinto, A. M., Barroso, S., Santo, J. E., Guedes, F., Monteiro, A., Sa, A., Furtado, I., Salazar, R., Aguilar, E. A., Herrero, F. R., Tabernero, J., Valera, J. S., Ayerbes, M. V., Batlle, J. F., Gil, S., Esteve, A. A., Garcia-Giron, C., Vivanco, G. L., Salvia, A. S., Orduña, V. A., Garcia, R. V., González-Gallego, J., Sureda, B. M., Remon, J., Safont Aguilera, M. J., Nogueras, L. C., Merino, B. Q., Castro, C. G., de Prado, P. M., Pericay, C. P., Figueiras, M. C., Jordan, I. G., Gome Reina, M. J., Garcia, A. L. L., Garcia-Ramos, A. A., Cervantes, A., Martos, C. F., Gaspar, E. M., Montero, I. C., Emperador, P. E., Carbonero, A. L., Castillo, M. G., Garcia, T. G., Lopez, J. G. S., Flores, E. G., Morales, M. G., Muñoz, M. L., Martín, A. L., Maurel, J., Camara, J. C., Garcia, R. D., Salgado, M., Busquier, I. H., Ruiz, T. C., Muñoa, A. L., Aliguer, M. N., de Taranco, A. V. O., Ureña, M. M., Gaspa, F. L., Ponce, J. J., Roig, C. B., Jimenez, P. V., Brotons, A. G., Rodriguez, S. A., Martinez, J. A., Ruiz, L. C., Ruiz, M. C., Bridgewater, J., Glynne-Jones, R., Tahir, S., Hickish, T., Cassidy, J. & Samuel, L., Sep 1 2017, In : European Journal of Cancer. 82, p. 16-24 9 p.

Research output: Contribution to journalArticle

2016

Adoptive immunotherapy against ovarian cancer

Mittica, G., Capellero, S., Genta, S., Cagnazzo, C., Aglietta, M., Sangiolo, D. & Valabrega, G., May 17 2016, In : Journal of Ovarian Research. 9, 1, 30.

Research output: Contribution to journalArticle

Cytokine-Induced Killer Cells Kill Chemosurviving Melanoma Cancer Stem Cells

Gammaitoni, L., Giraudo Diego, L., Macagno, M., Leuci, V., Mesiano, G., Rotolo, R., Sassi, F., Sanlorenzo, M., Zaccagna, A., Pisacane, A., Senetta, R., Cangemi, M., Cattaneo, G., Martin, V., Coha, V., Gallo, S., Pignochino, Y., Sapino, A., Grignani, G., Carnevale Schianca, F. & 2 others, Aglietta, M. & Sangiolo, D., 2016, In : Clinical Cancer Research.

Research output: Contribution to journalArticle

Establishment of a patient-derived intrahepatic cholangiocarcinoma xenograft model with KRAS mutation

Cavalloni, G., Peraldo-Neia, C., Sassi, F., Chiorino, G., Sarotto, I., Aglietta, M. & Leone, F., Feb 11 2016, In : BMC Cancer. 16, 1, 90.

Research output: Contribution to journalArticle

Gene and microRNA modulation upon trabectedin treatment in a human intrahepatic cholangiocarcinoma paired patient derived xenograft and cell line

Peraldo Neia, C., Cavalloni, G., Chiorino, G., Ostano, P., Aglietta, M. & Leone, F., 2016, In : Oncotarget. 7, 52, p. 86766-86780 15 p.

Research output: Contribution to journalArticle

Lenalidomide normalizes tumor vessels in colorectal cancer improving chemotherapy activity

Leuci, V., Maione, F., Rotolo, R., Giraudo, E., Sassi, F., Migliardi, G., Todorovic, M., Gammaitoni, L., Mesiano, G., Giraudo, L., Luraghi, P., Leone, F., Bussolino, F., Grignani, G., Aglietta, M., Trusolino, L., Bertotti, A. & Sangiolo, D., May 5 2016, In : Journal of Translational Medicine. 14, 1, 119.

Research output: Contribution to journalArticle

Panitumumab in combination with gemcitabine and oxaliplatin does not prolong survival in wild-type KRAS advanced biliary tract cancer: A randomized phase 2 trial (Vecti-BIL study)

Leone, F., Marino, D., Cereda, S., Filippi, R., Belli, C., Spadi, R., Nasti, G., Montano, M., Amatu, A., Aprile, G., Cagnazzo, C., Fasola, G., Siena, S., Ciuffreda, L., Reni, M. & Aglietta, M., Feb 15 2016, In : Cancer. 122, 4, p. 574-581 8 p.

Research output: Contribution to journalArticle

Panitumumab in combination with gemcitabine and oxaliplatin does not prolong survival in wild-type KRAS advanced biliary tract cancer: A randomized phase 2 trial (Vecti-BIL study)

Leone, F., Marino, D., Cereda, S., Filippi, R., Belli, C., Spadi, R., Nasti, G., Montano, M., Amatu, A., Aprile, G., Cagnazzo, C., Fasola, G., Siena, S., Ciuffreda, L., Reni, M. & Aglietta, M., Feb 15 2016, In : Cancer. 122, 4, p. 574-581 8 p.

Research output: Contribution to journalArticle

Phase 1B/2 study of the HSP90 inhibitor AUY922 plus trastuzumab in metastatic HER2-positive breast cancer patients who have progressed on trastuzumab-based regimen

Kong, A., Rea, D., Ahmed, S., Beck, J. T., López, R. L., Biganzoli, L., Armstrong, A. C., Aglietta, M., Alba, E., Campone, M., Schmitz, S. F. H., Lefebvre, C., Akimov, M. & Lee, S. C., 2016, In : Oncotarget. 7, 25, p. 37680-37692 13 p.

Research output: Contribution to journalArticle

Preclinical activity of EGFR and MEK1/2 inhibitors in the treatment of biliary tract carcinoma

Cavalloni, G., Peraldo-Neia, C., Varamo, C., Chiorino, G., Sassi, F., Aglietta, M. & Leone, F., Aug 1 2016, In : Oncotarget. 7, 32, p. 52354-52363 10 p.

Research output: Contribution to journalArticle

Xenopatients show the need for precision medicine approach to chemotherapy in ovarian cancer

Erriquez, J., Olivero, M., Mittica, G., Scalzo, M. S., Vaira, M., De Simone, M., Ponzone, R., Katsaros, D., Aglietta, M., Calogero, R., Di Renzo, M. F. & Valabrega, G., May 1 2016, In : Oncotarget. 7, 18, p. 26181-26191 11 p.

Research output: Contribution to journalArticle

Xenopatients show the need for precision medicine approach to chemotherapy in ovarian cancer

Erriquez, J., Olivero, M., Mittica, G., Scalzo, M. S., Vaira, M., Simone, M., Ponzone, R., Katsaros, D., Aglietta, M., Calogero, R. A., Di Renzo, M. F. & Valabrega, G., May 1 2016, In : Oncotarget. 7, 18, p. 26181-26191 11 p.

Research output: Contribution to journalArticle

2015

Adoptive immunotherapy against sarcomas

Mesiano, G., Leuci, V., Giraudo, L., Gammaitoni, L., Carnevale Schianca, F., Cangemi, M., Rotolo, R., Capellero, S., Pignochino, Y., Grignani, G., Aglietta, M. & Sangiolo, D., Apr 1 2015, In : Expert Opinion on Biological Therapy. 15, 4, p. 517-528 12 p.

Research output: Contribution to journalArticle

A retrospective analysis of the activity and safety of oral etoposide in heavily pretreated metastatic breast cancer patients

Valabrega, G., Berrino, G., Milani, A., Aglietta, M. & Montemurro, F., May 1 2015, In : Breast Journal. 21, 3, p. 241-245 5 p.

Research output: Contribution to journalArticle

Circannual variation of efficacy outcomes in patients with newly diagnosed metastatic colorectal cancer and treated with first-line chemotherapy

Tampellini, M., Polverari, R. S., Ottone, A., Alabiso, I., Baratelli, C., Bitossi, R., Brizzi, M. P., Leone, F., Forti, L., Bertona, E., Racca, P., Mecca, C., Alabiso, O., Aglietta, M., Berruti, A. & Scagliotti, G. V., Nov 26 2015, In : Chronobiology International. 32, 10, p. 1359-1366 8 p.

Research output: Contribution to journalArticle

Cytokine-induced killer cells as immunotherapy for solid tumors: Current evidence and perspectives

Giraudo, L., Gammaitoni, L., Cangemi, M., Rotolo, R., Aglietta, M. & Sangiolo, D., Sep 1 2015, In : Immunotherapy. 7, 9, p. 999-1010 12 p.

Research output: Contribution to journalArticle

Cytokine Induced Killer cells effectively kill chemo-resistant melanoma cancer stem cells

Gammaitoni, L., Giraudo, L., Leuci, V., Mesiano, G., Cangemi, M., Zaccagna, A., Pisacane, A., Gallo, S., Carnevale-Schianca, F., Aglietta, M. & Sangiolo, D., Jan 15 2015, (Accepted/In press) In : Journal of Translational Medicine. p. 1-2 2 p.

Research output: Contribution to journalArticle

Establishment and characterization of a human intrahepatic cholangiocarcinoma cell line derived from an Italian patient

Cavalloni, G., Peraldo-Neia, C., Varamo, C., Casorzo, L., Dell’Aglio, C., Bernabei, P., Chiorino, G., Aglietta, M. & Leone, F., Oct 20 2015, (Accepted/In press) In : Tumor Biology.

Research output: Contribution to journalArticle

Sorafenib and everolimus for patients with unresectable high-grade osteosarcoma progressing after standard treatment: A non-randomised phase 2 clinical trial

Grignani, G., Palmerini, E., Ferraresi, V., D'Ambrosio, L., Bertulli, R., Asaftei, S. D., Tamburini, A., Pignochino, Y., Sangiolo, D., Marchesi, E., Capozzi, F., Biagini, R., Gambarotti, M., Fagioli, F., Casali, P. G., Picci, P., Ferrari, S. & Aglietta, M., 2015, In : The Lancet Oncology. 16, 1, p. 98-107 10 p.

Research output: Contribution to journalArticle

Synergy of molecular targeted approaches and immunotherapy in melanoma: Preclinical basis and clinical perspectives

Sanlorenzo, M., Vujic, I., Moy, A., Quaglino, P., Fierro, M. T., Gammaitoni, L., Carnevale-Schianca, F., Aglietta, M. & Sangiolo, D., Oct 3 2015, In : Expert Opinion on Biological Therapy. 15, 10, p. 1491-1500 10 p.

Research output: Contribution to journalArticle

The combination of sorafenib and everolimus shows antitumor activity in preclinical models of malignant pleural mesothelioma

Pignochino, Y., Dell'Aglio, C., Inghilleri, S., Zorzetto, M., Basiricò, M., Capozzi, F., Canta, M., Piloni, D., Cemmi, F., Sangiolo, D., Gammaitoni, L., Soster, M., Marchiò, S., Pozzi, E., Morbini, P., Luisetti, M., Aglietta, M., Grignani, G. & Stella, G. M., May 8 2015, In : BMC Cancer. 15, 1, 374.

Research output: Contribution to journalArticle

TOP2A gene copy gain predicts response of epithelial ovarian cancers to pegylated liposomal doxorubicin: TOP2A as marker of response to PLD in ovarian cancer

Erriquez, J., Becco, P., Olivero, M., Ponzone, R., Maggiorotto, F., Ferrero, A., Scalzo, M. S., Canuto, E. M., Sapino, A., Verdun Di Cantogno, L., Bruna, P., Aglietta, M., Di Renzo, M. F. & Valabrega, G., Sep 1 2015, In : Gynecologic Oncology. 138, 3, p. 627-633 7 p.

Research output: Contribution to journalArticle

2014

Activity of cytokine-induced killer cells against bone and soft tissue sarcoma

Sangiolo, D., Mesiano, G., Gammaitoni, L., Aglietta, M. & Grignani, G., 2014, In : OncoImmunology. 3, 3, e28269.

Research output: Contribution to journalArticle

Anti-cancer effect and gene modulation of ET-743 in human biliary tract carcinoma preclinical models

Peraldo-Neia, C., Cavalloni, G., Soster, M., Gammaitoni, L., Marchiò, S., Sassi, F., Trusolino, L., Bertotti, A., Medico, E., Capussotti, L., Aglietta, M. & Leone, F., Dec 5 2014, In : BMC Cancer. 14, 1, 918.

Research output: Contribution to journalArticle

Anticoagulation for central venous catheters in patients with Cancer

D'Ambrosio, L., Aglietta, M., Grignani, G. & Kotsiopoulos, D., Oct 2 2014, In : New England Journal of Medicine. 371, 14, p. 1362-1363 2 p.

Research output: Contribution to journalArticle

Anticoagulation for central venous catheters in patients with cancer.

D'Ambrosio, L., Aglietta, M. & Grignani, G., 2014, In : New England Journal of Medicine. 371, 14, p. 1362-1363 2 p.

Research output: Contribution to journalArticle

A phase I dose escalation trial of tremelimumab (CP-675,206) in combination with gemcitabine in chemotherapy-naive patients with metastatic pancreatic cancer

Aglietta, M., Barone, C., Sawyer, M. B., Moore, M. J., Miller, W. H., Bagalà, C., Colombi, F., Cagnazzo, C., Gioeni, L., Wang, E., Huang, B., Fly, K. D. & Leone, F., 2014, In : Annals of Oncology. 25, 9, p. 1750-1755 6 p., mdu205.

Research output: Contribution to journalArticle